Predominance of trisomy 1q in myelodysplastic syndromes in Korea: Is there an ethnic difference? A 3-year multi-center study

Cancer Genetics and Cytogenetics

Volumn 132, Issue 2, 2002, Pages 97-101

  Lee, Dong Soon ^a   Kim, Sun Hee ^b   Seo, Eul Ju ^c   Park, Chan Jung ^c   Chi, Hyun Sook ^c   Ko, Eun Kyoung ^a   Yoon, Byoung Hak ^a   Kim, Wo Ho ^d   Cho, Han Ik ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 1Q; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME DELETION 5; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOGENETICS; ETHNIC DIFFERENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GEOGRAPHIC DISTRIBUTION; HUMAN; KOREA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REFRACTORY ANEMIA; TRISOMY; TRISOMY 1Q; TRISOMY 8;

CHROMOSOMES, HUMAN, PAIR 1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KOREA; MYELODYSPLASTIC SYNDROMES; TRISOMY;

SOLEA SOLEA;

EID: 0037081847     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(01)00533-7     Document Type: Article

References (25)

1. Proposals for the classification of the myelodysplastic syndromes
2. Cytogenetic findings in primary and secondary MDS
3. Myelodysplastic (preleukemic) Syndrome
4. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure
5. Myelodysplasia
6. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system; a report on 408 cases
7. Chromosomal deletions in the myelodysplastic syndrome
8. Chromosome study of 85 patients with myelodysplastic syndrome
9. Chromosome abnormalities in myelodysplastic syndromes
10. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes; a multicentric study in Japan
11. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes
12. Clinical-cytogenetic correlations in myelodysplasia (preleukemia)
13. Chemicals and leukemia
14. Cytogenetic findings in 179 patients with myelodysplastic syndromes
15. Unbalanced 1;7 translocation in myelodysplastic syndrome following treatment of acute myeloblastic leukemia with an 8;21 translocation
16. The unbalanced 1;7 translocation in de novo myelodysplastic syndrome and its clinical implication
17. Cytogenetics of myelodysplastic syndromes
18. Aetiology of acute leukemia
19. Cytogenetic analysis of 54 cases of myelodysplastic syndrome
20. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome. Prognostic significance of morphology and chromosome findings
21. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome
22. Cytogenetic studies, ras mutation, and clinical characteristics in primary myelodysplastic syndrome. A study on 68 Chinese patients in Taiwan
23. Interphase fluorescence in situ hybridization overcomes pitfalls of G-banding analysis with special reference to underestimation of chromosomal aberration rates